We are live on
!
Find out more
ACA
AYAL Capital Advisors Portfolio holdings
AUM
$369M
1-Year Est. Return
39.67%
This Fund
S&P 500
This Quarter
Est. Return
+11.41%
1 Year Est. Return
+39.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$239M
AUM Growth
–
Cap. Flow
+$225M
Cap. Flow
% of AUM
94.1%
Top 10 Holdings %
Top 10 Hldgs %
60.77%
Holding
36
New
36
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arcosa
ACA
|
+$11.5M |
| 2 |
MDU Resources
MDU
|
+$10.2M |
| 3 |
Fluor
FLR
|
+$6.42M |
| 4 |
Orthofix Medical
OFIX
|
+$5.58M |
| 5 |
Charles River Laboratories
CRL
|
+$5.57M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.34% |
| 2 | Consumer Discretionary | 11.3% |
| 3 | Healthcare | 7.76% |
| 4 | Materials | 5.34% |
| 5 | Utilities | 4.43% |
Similar funds
CWM
EWM
W
MB
RPA
MI
FAFC
CCM
AYAL Capital Advisors's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for AYAL Capital Advisors, which disclosed 36 positions worth $239M. Its ten largest holdings account for 61% of the portfolio.
Its largest position is Arcosa: 157,105 shares worth $13M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, followed by Consumer Discretionary and Healthcare.
- AYAL Capital Advisors's largest Q4 2023 buy was Arcosa: 157,105 shares worth $13M.
- AYAL Capital Advisors's ten largest holdings make up 61% of its $239M portfolio in Q4 2023.
- AYAL Capital Advisors disclosed 36 positions in Q4 2023, its first 13F filing on record.
Based on AYAL Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.